M11.25
Other chondrocalcinosis, hip
Clinical Classification Guidelines
Medical Intelligence & Overview
Chondrocalcinosis of the hip, classified under ICD-10 code M11.25, is a condition characterized by the abnormal accumulation of calcium crystals within the cartilage of the hip joint. This condition often results in joint pain, stiffness, and reduced mobility. It is a type of joint disease that can affect individuals of various ages, but it is more common in older adults. Chondrocalcinosis is sometimes associated with other metabolic conditions, and understanding its nature can help in managing symptoms and improving quality of life.
Causes & Symptoms
Clinical Causes: Aging processes leading to cartilage degeneration Metabolic disorders such as calcium pyrophosphate dihydrate (CPPD) crystal deposition disease Genetic predispositions impacting calcium and phosphate metabolism Previous joint injuries or surgeries Underlying conditions such as hyperparathyroidism, hemochromatosis, or hypothyroidism Chronic joint stress or repetitive injuries
Key Symptoms: Joint pain, especially during movement or weight-bearing activities Stiffness in the affected hip Swelling and warmth around the joint Reduced range of motion in the hip Crepitus, or a grating sensation within the joint during movement Persistent discomfort that may worsen over time
Diagnostic & Treatment
Diagnosis Path: Diagnosis of chondrocalcinosis of the hip involves a combination of clinical evaluation and imaging studies. Medical professionals typically perform a physical examination to assess joint swelling, warmth, and range of motion. Imaging techniques such as X-rays are used to identify calcium crystal deposits within the cartilage, which appear as calcifications in the joint space. Occasionally, joint fluid analysis is performed where a sample of synovial fluid is examined under a microscope to detect calcium pyrophosphate crystals confirming the diagnosis. Laboratory tests may also be ordered to investigate underlying metabolic abnormalities linked to the condition.
Treatment Protocols: Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation Corticosteroid injections directly into the joint for flare-ups Physical therapy to enhance joint strength and flexibility Application of heat or cold therapy to alleviate discomfort Lifestyle modifications such as weight management to decrease joint stress In some cases, joint aspiration to remove excess fluid Surgical intervention, including joint replacement, may be considered in advanced cases where conservative treatments fail
Clinical Advice & FAQs
Billing Guidance
Is M11.25 a billable ICD-10 code?
Yes, M11.25 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.25?
Clinical documentation must specify the nature of Other chondrocalcinosis, hip and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
